Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
29.71
-0.26 (-0.87%)
At close: Dec 20, 2024, 4:00 PM
31.51
+1.80 (6.07%)
After-hours: Dec 20, 2024, 6:34 PM EST
Alkermes Employees
Alkermes had 2,100 employees as of December 31, 2023. The number of employees decreased by 180 or -7.89% compared to the previous year.
Employees
2,100
Change (1Y)
-180
Growth (1Y)
-7.89%
Revenue / Employee
$716,724
Profits / Employee
$158,736
Market Cap
4.81B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Integer Holdings | 10,500 |
RadNet | 8,441 |
BridgeBio Pharma | 556 |
Axsome Therapeutics | 545 |
Corcept Therapeutics | 352 |
Crinetics Pharmaceuticals | 290 |
TG Therapeutics | 264 |
Krystal Biotech | 229 |
ALKS News
- 25 days ago - Alkermes to Participate in Upcoming Investor Conferences - PRNewsWire
- 26 days ago - Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth - Seeking Alpha
- 5 weeks ago - Alkermes to Participate in Two Upcoming Investor Conferences - PRNewsWire
- 6 weeks ago - Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences - PRNewsWire
- 2 months ago - Alkermes plc (ALKS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Alkermes plc Reports Third Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Alkermes to Report Third Quarter Financial Results on October 24, 2024 - PRNewsWire
- 3 months ago - Alkermes to Host Investor Event to Review Orexin Portfolio Strategy - PRNewsWire